Robert Alexander Ingram, 10% Owner, Director at Clearside Biomedical, Inc. (CLSD), bought 414,286 shares at $7.00 ($2.9M) on 2016-06-07, disclosed to the SEC on 2016-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| NOVN | BUY | 2019-05-23 | $111K | — | Filing → |
| NOVN | BUY | 2018-10-01 | $142K | — | Filing → |
| NOVN | BUY | 2017-08-29 | $55K | — | Filing → |